107 related articles for article (PubMed ID: 15708183)
1. Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease.
Lemos PA; de Feyter PJ; Serruys PW; Saia F; Arampatzis CA; Disco C; Mercado N; Mainar V; Morís C; van den Bos AA; Berghoefer G
Int J Cardiol; 2005 Feb; 98(3):479-86. PubMed ID: 15708183
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
Arampatzis CA; Goedhart D; Serruys PW; Saia F; Lemos PA; de Feyter P;
Am Heart J; 2005 Feb; 149(2):329-35. PubMed ID: 15846273
[TBL] [Abstract][Full Text] [Related]
3. Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy).
Lemos PA; Serruys PW; de Feyter P; Mercado NF; Goedhart D; Saia F; Arampatzis CA; Soares PR; Ciccone M; Arquati M; Cortellaro M; Rutsch W; Legrand V
Am J Cardiol; 2005 Feb; 95(4):445-51. PubMed ID: 15695126
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
Holdaas H; Fellström B; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Logan JO; Staffler B; Gimpelewicz C;
Nephrol Dial Transplant; 2005 May; 20(5):974-80. PubMed ID: 15784644
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
[TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention.
Delea TE; Jacobson TA; Serruys PW; Edelsberg JS; Oster G
Ann Pharmacother; 2005 Apr; 39(4):610-6. PubMed ID: 15741421
[TBL] [Abstract][Full Text] [Related]
8. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
[TBL] [Abstract][Full Text] [Related]
9. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
[TBL] [Abstract][Full Text] [Related]
10. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
[TBL] [Abstract][Full Text] [Related]
11. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
[TBL] [Abstract][Full Text] [Related]
13. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
Holdaas H; Wanner C; Abletshauser C; Gimpelewicz C; Isaacsohn J
Int J Cardiol; 2007 Apr; 117(1):64-74. PubMed ID: 16889855
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
Mood GR; Bavry AA; Roukoz H; Bhatt DL
Am J Cardiol; 2007 Sep; 100(6):919-23. PubMed ID: 17826370
[TBL] [Abstract][Full Text] [Related]
15. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
[TBL] [Abstract][Full Text] [Related]
16. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
Soares PR; Hueb WA; Lemos PA; Lopes N; Martinez EE; Cesar LA; Oliveira SA; Ramires JA
Circulation; 2006 Jul; 114(1 Suppl):I420-4. PubMed ID: 16820611
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
Foley DP; Serruys PW
Br J Clin Pract Suppl; 1996 Jan; 77A():40-53. PubMed ID: 8729590
[TBL] [Abstract][Full Text] [Related]
18. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
[TBL] [Abstract][Full Text] [Related]
19. Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting.
Kandzari DE; Tuttle RH; Zidar JP; Jollis JG
Am J Cardiol; 2006 May; 97(10):1467-72. PubMed ID: 16679085
[TBL] [Abstract][Full Text] [Related]
20. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
